Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals

BACKGROUND:Evidence is conflicting about the association of abacavir use and cardiovascular disease (CVD) among HIV-infected individuals. Previous studies may have been biased by the preferential initiation or continuation of abacavir in patients with renal dysfunction. METHODS:We conducted a cohort...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2016-04, Vol.71 (4), p.413-419
Hauptverfasser:	Marcus, Julia L, Neugebauer, Romain S, Leyden, Wendy A, Chao, Chun R, Xu, Lanfang, Quesenberry, Charles P, Klein, Daniel B, Towner, William J, Horberg, Michael A, Silverberg, Michael J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS/HIV Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Antiretroviral drugs California - epidemiology Cardiovascular disease Cardiovascular Diseases - chemically induced Demographics Dideoxynucleosides - adverse effects Dideoxynucleosides - therapeutic use HIV HIV Infections - complications HIV Infections - drug therapy HIV Infections - epidemiology Human immunodeficiency virus Humans Lipids Middle Aged Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!